MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma ...

FDA Recall #D-0532-2023 — Class III — March 8, 2023

Recall #D-0532-2023 Date: March 8, 2023 Classification: Class III Status: Ongoing

Product Description

MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma Inc., a wholly owned subsidiary of Pfizer Inc., Boulder, CO 80301. NDC: 70255-010-02

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle labels state an expiry date of March 2026; the correct expiration date is February 2025.

Recalling Firm

Pfizer Inc. — New York, NY

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

1,926 Bottles

Distribution

Nationwide in the USA

Code Information

Lot W054586A, EXP 03/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated